EVOKE PHARMA, INC. Deferred Offering Costs

EVOKE PHARMA, INC. Deferred Offering Costs

EVOKE PHARMA, INC. had Deferred Offering Costs of $138.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-10.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:DeferredOfferingCosts · last filed 2016-03-10

• 2015-12-31: Deferred Offering Costs $138.00K.
• 2014-12-31: Deferred Offering Costs $138.00K.